Consequently, elevated levels of MYCN, either through amplification or due to Akt-mediated GSK-3b inactivation, would suppress DPYSL3 in NB cells (Le Grand et al., 2020; Gao et al., 2024). The gene discussed is GSK3B; the disease is neuroblastoma.